XORTX Therapeutics, Inc. (XRTX)
2.25
-0.03
(-1.32%)
USD |
NASDAQ |
Sep 09, 10:55
XORTX Therapeutics Total Assets (Quarterly) : 6.184M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.184M |
| March 31, 2026 | 2.145M |
| December 31, 2025 | 2.684M |
| September 30, 2025 | 2.811M |
| June 30, 2025 | 2.742M |
| March 31, 2025 | 3.499M |
| December 31, 2024 | 4.094M |
| September 30, 2024 | 3.850M |
| June 30, 2024 | 4.799M |
| March 31, 2024 | 6.051M |
| December 31, 2023 | 5.468M |
| September 30, 2023 | 6.640M |
| June 30, 2023 | 7.801M |
| March 31, 2023 | 9.659M |
| December 31, 2022 | 12.36M |
| September 30, 2022 | 10.89M |
| June 30, 2022 | 12.44M |
| Date | Value |
|---|---|
| March 31, 2022 | 14.76M |
| December 31, 2021 | 17.45M |
| September 30, 2021 | 6.183M |
| June 30, 2021 | 5.922M |
| March 31, 2021 | 6.562M |
| December 31, 2020 | 1.798M |
| September 30, 2020 | 1.995M |
| June 30, 2020 | 2.111M |
| March 31, 2020 | 2.360M |
| December 31, 2019 | 0.839M |
| September 30, 2019 | 0.8128M |
| June 30, 2019 | 0.8318M |
| March 31, 2019 | 0.8445M |
| December 31, 2018 | 0.9264M |
| September 30, 2018 | 1.050M |
| June 30, 2018 | 1.199M |
| March 31, 2018 | 1.412M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Lexaria Bioscience Corp. | 4.781M |
| InMed Pharmaceuticals, Inc. | 9.134M |
| Target Group, Inc. (Canada) | 5.678M |
| NervGen Pharma Corp. | 63.57M |
| Milestone Pharmaceuticals, Inc. | 181.62M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.6795M |
| Shareholders Equity (Quarterly) | 5.505M |
| Current Ratio | 3.586 |
| Net Debt Paydown Yield | 0.08% |